Speaker Profile
PhD, Director of the Office of Advanced Molecular Detection (OAMD), CDC SPHERES Consortium
Biography
Duncan MacCannell is the Director of the Office of Advanced Molecular Detection (OAMD) at the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) at the CDC. He has been instrumental in using emerging next generation sequencing technologies to transform infectious disease public health, leading to the establishment of the Advanced Molecular Detection (AMD) Program in 2014. He has guided the program's development and application of sequencing and high performance computing to public health priorities such as detecting and responding to outbreaks and identifying emerging infectious threats. During the pandemic response, Dr. MacCannell established the CDC SPHERES Consortium, which tracks the spread and evolution of SARSCoV2, the virus that causes COVID19. He leads the consortium's efforts to monitor the emergence and spread of new SARSCoV2 variants, which is critical for informing public health decision making, tracking the evolution of infectious diseases and to inform public health policy.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair:
Gad Getz, Broad Institute
- PMWC 2024 Luminary Award
Luminary Honoree: Heidi Rehm, MGH and Broad Institute
- Opening Talk: The Power of Data by Track Chair Gaddy Getz, Broad Institute
- Challenges of Remote Data Harmonization and Querying (PANEL)
Chair: Heidi Rhem, MGH and Broad Institute
- Chris Lunt, All of Us
- Simona Carini, UCSF
- Josh Peterson, Emerge/Vanderbilt University Medical Center
- Nara Sobreira, Johns Hopkins/GeneMatcher - Promoting Global Collaboration for Data Sharing: Overcoming Organizational and Sectoral Barriers (PANEL)
Chair: Gad Getz, Broad Institute
- Peter Goodhand, GA4GH
- Valentina Di Francesco, NHGRI
- Melanie Courtot, ICGC-ARGO
- Erica Galvez, Manifest MedEx - Keynote: Machine Learning for Therapeutic Discovery
- Daphne Koller, insitro
- Exploring the Power of AI and Data Sciences in Drug Discovery (PANEL)
Chair: Michelle Chen, Insilico Medicine
- Kim Branson, GSK
- Laszlo Radvanyi, Ontario Institute for Cancer Research
- Martin Stumpe, Tempus
- Sun-Gou Ji, BridgeBio
- Angela Oliveira Pisco, Insitro - Foundation Models to Advance Precision Medicine (PANEL)
Chair: Nigam Shah, Stanford
- Aashima Gupta, Google
- Rod Tarrago, AWS
- Lana Feng, Huma.ai - PMWC Showcase
- Janusz Dutkowski, Data4Cure
